共 1 条
[1]
Klein AL(2020)Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis N. Engl. J. Med. undefined undefined-undefined
The IL-1 trap rilonacept resolves and prevents recurrent pericarditis
被引：0
作者：
Irene Fernández-Ruiz
机构：
[1] Nature Reviews Cardiology,
来源：
Nature Reviews Cardiology
|
2021年
/
18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In patients with recurrent pericarditis, treatment with rilonacept, an engineered fusion protein that acts as an IL-1 trap, leads to a rapid resolution of recurrent pericarditis episodes and reduces the risk of pericarditis recurrence.
引用
收藏
页码：73 / 73
相关论文